Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6055237 | Oral Oncology | 2013 | 5 Pages |
Abstract
When cisplatin is contraindicated, carboplatin-based CRT yields equivalent treatment outcomes in patients with LASCCHN.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
A.C. Wilkins, N. Rosenfelder, U. Schick, S. Gupta, K. Thway, C.M. Nutting, K.J. Harrington, K. Newbold, S.A. Bhide,